BILLS-119hr1262eh.pdf

later than one year later than 12 months 3 years annually 21 U.S.C. 333 180 days 1ST SESSION H. R. 1262 each of fiscal years 2025 later than two years later than 10 years December 1 later than 8 years 42 U.S.C. later than 2 years 7-year 1996 42 U.S.C. 284m(d)(1 later than 3 years U.S.C. 1 5 years 45-day 21 U.S.C. 355c at least 60 days September 30, 2029 later than 6 years

SESSION H. R. 1262

the United States United States the United States of America

Cosmetic

the Federal Food, Drug SEC U.S.C. the Federal Food Labor Senate Food, Drug the Public Health Service Act CONGRESS Energy and Commerce Federal Food, Drug Federal the Abraham Accords Office Health and Human Services the House of Representatives Drug Administration Food and Drug Administration House Transplantation Network the Food and Drug Administration FDA GAO GAO STUDY Health, Education Representatives QUIREMENTS Health Organ ABRAHAM ACCORDS OFFICE MENTS AUTHORITY the Food and Drug Administra- United the Public Health Service Procurement and Transplantation Network United States Government tronic health records systems House of Representa- Organ Procurement and Transplantation Network tem the Committee on Health Health Insurance the Food and Drug Admin- LARLY TARGETED CANCER DRUGS PLETED Office

Abraham Accords Abraham the Mikaela Naylon Give Kids Mikaela Naylon

pediatric cancer drug biological targeted drugs food drug active product sec research investigation referred paragraph table contents study approved